Currier has acquired Sage Product Development, Inc. for an undisclosed amount. The transaction, which closed recently, brings the medical device engineering consultancy fully under Currier’s ownership. Sage will operate as a distinct unit within Currier’s existing structure, with its current leadership remaining in place to manage day-to-day operations.
Sage Product Development, Inc. is a focused team of experienced medical device engineers that provides fast, efficient, and creative product development services. Its client base spans startups, multinational corporations, and mid-sized firms, with a business model built on a high level of expertise paired with a low overhead structure. The company is known for solving technical challenges and delivering product development needs in a timely, personalized manner.
Currier, the acquiring firm, has been expanding its capabilities in the medical technology sector. The purchase of Sage adds a dedicated product development arm to Currier’s portfolio, which previously lacked an in-house engineering consultancy of this scale. For Currier, the deal reduces reliance on external contractors for early-stage device design and regulatory prototyping, a segment that has grown more competitive in recent years.
For Sage, the acquisition provides access to Currier’s broader operational resources, including supply chain management and commercial distribution channels. Sage’s engineers will retain their hands-on approach, but they can now draw on Currier’s infrastructure for larger, multi-phase projects. Currier expects the combined entity to shorten time-to-market for clients developing Class II and Class III devices, though no specific product timelines have been disclosed.
The integration is expected to proceed without major changes to Sage’s client contracts or staffing levels. Currier has indicated that Sage’s existing project commitments will be honored as-is. The combined company will now offer a seamless path from concept development through manufacturing, a capability that neither firm possessed independently at the same scale. Market observers will watch whether this consolidation prompts similar moves among other mid-sized engineering consultancies in the medical device space.